经导管主动脉瓣置入术后无导线起搏器植入1例A case report of leadless pacemaker implantation after transcatheter aortic valve implantation
阳辉,刘振江,吴陈璐,方臻飞,刘启明,周胜华
摘要(Abstract)：
经导管主动脉瓣置入术（TAVI）术后有发生房室传导阻滞的风险，一旦出现不可逆的传导阻滞则需要植入永久起搏器治疗。本文报道了我院采用无导线起搏器治疗1例TAVI术后三度房室传导阻滞高龄患者，减少了该患者因不能中断抗血小板治疗而合并的穿刺及囊袋出血感染风险，临床效果满意。
关键词(KeyWords)： 经导管主动脉瓣置入术;房室传导阻滞
基金项目(Foundation): 国家自然科学基金面上项目（81870258、82150006）;; 湖南省自然科学基金面上项目（2022JJ30853）;湖南省自然科学基金科卫联合基金项目（2022JJ70052）
作者(Author): 阳辉,刘振江,吴陈璐,方臻飞,刘启明,周胜华
参考文献(References)：
- [1] Dai Y, Chen KP, Hua W, et al. Dual antiplatelet therapy increases pocket hematoma complications in Chinese patients with pacemaker implantation[J]. J Geriatr Cardiol, 2015, 12(4):383-387.
- [2] Bernard ML, Shotwell M, Nietert PJ, et al. Meta-analysis of bleeding complications associated with cardiac rhythm device implantation[J]. Circ Arrhythm Electrophysiol, 2012, 5(3):468-474.
- [3] Eliav R, Elitzur Y, Planer D, et al. Predictors for permanent pacemaker implantation following transcatheter aortic valve implantation:trends over the past decade[J]. J Interv Card Electrophysiol, 2020, 62(2):299-307.
- [4] Glikson M, Nielsen JC, Kronborg MB, et al. 2021ESC Guidelines on cardiac pacing and cardiac resynchronization therapy[J]. Eur Heart J, 2021, 42(35):3427-3520.
- [5] Kirkfeldt RE, Johansen JB, Nohr EA, et al. Complications after cardiac implantable electronic device implantations:an analysis of a complete, nationwide cohort in Denmark[J]. Eur Heart J, 2014, 35(18):1186-1194.
- [6] Udo EO, Zuithoff NPA, van Hemel NM, et al. Incidence and predictors of short-and long-term complications in pacemaker therapy:the FOLLOWPACE study[J]. Heart Rhythm,2012, 9(5):728-735.
- [7] Kirkfeldt RE, Johansen JB, Nohr EA, et al. Pneumothorax in cardiac pacing:a population-based cohort study of 28860Danish patients[J]. Europace, 2012, 14(8):1132-1138.
- [8] Kiviniemi MS, Pirnes MA, Er?nen HJ, et al. Complications related to permanent pacemaker therapy[J]. Pacing Clin Electrophysiol, 1999, 22(5):711-720.
- [9] Ellenbogen KA, Hellkamp AS, Wilkoff BL, et al.Complications arising after implantation of DDD pacemakers:the MOST experience[J]. Am J Cardiol, 2003, 92(6):740-741.
- [10] Brunner MP, Cronin EM, Wazni O, et al. Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction[J].Heart Rhythm, 2014, 11(3):419-425.
- [11] Tarakji KG, Wazni OM, Harb S,et al. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction:the impact of the infection type and the presence of vegetation on survival[J]. Europace, 2014, 16(10):1490-1495.
- [12] Essebag V, Verma A, Healey JS, et al. Clinically significant pocket hematoma increases long-term risk of device infection:BRUISE CONTROL INFECTION Study[J]. J Am Coll Cardiol, 2016, 67(11):1300-1308.
- [13] Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections:Leiden device registry[J]. Heart, 2009, 95(9):715-720.
- [14]中国医师协会心律学专业委员会，中华医学会心电生理和起搏分会.无导线起搏器临床应用中国专家共识（2022）[J].中华心律失常学杂志，2022, 26(3):263-271.
- [15] Xiao Y, Zhou S, Liu Q. A leadless cardiac pacemaker[J]. N Engl J Med, 2016, 374(6):593-594.